Search
for
Sort by
Research 751–780 of 1000+
- Regularities of Change Concentrations of Interleukin-17A, Interleukin-2 and Interleukin-10 in the Blood of People with Alopecia Areata before and after Treatment with Platelet-Rich Plasma
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Baricitinib for the treatment of alopecia areata in adults: Real-world analysis of 36 patients
- Establishing and prioritizing research questions for the prevention, diagnosis and treatment of hair loss (excluding alopecia areata): the Hair Loss Priority Setting Partnership
- Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment
- Upadacitinib for the treatment of refractory alopecia areata in pediatric patients: A retrospective study
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- A Comprehensive Review on Alopecia Areata and its Pathophysiology, Diagnosis, Treatment, and Psychosocial Impact
- A Comprehensive Review on Alopecia Areata and its Pathophysiology, Diagnosis, Treatment, and Psychosocial Impact
- An Interventional, Comparative, Prospective Study to Determine Optimum Concentration of Intralesional Triamcinolone Acetonide in Treatment of Alopecia Areata
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- THE PATTERN AND CLINICAL PROFILE OF ALOPECIA AREATA. PANORAMIC REVIEW: UPDATE AND ADVANCES ON ETIOPATHOGENESIS, ASSOCIATED FACTORS, DIAGNOSIS, COMPLICATIONS, MANAGEMENT AND PROGNOSIS IN TREATMENT 2023
- (R.) "Efficacy of Intralesional Injection of Vitamin D3 in treatment of Alopecia Areata"
- Topical minoxidil in the treatment of alopecia areata
- Topical minoxidil in the treatment of alopecia areata
- Iontophoresis as a potential treatment for alopecia areata incognita
- Combination oral minoxidil and baricitinib treatment of alopecia areata
- 73338 Upadacitinib for the Treatment of Refractory Alopecia Areata in Pediatric Patients: A Retrospective Study
- A randomized, double-blind controlled clinical study to evaluate the efficacy and safety of minoxidil topical 2% nanosuspension with aqueous base in the treatment of androgenetic alopecia areata
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Role of systemic minoxidil in the treatment of alopecia areata: A scoping review to direct future research
- Effectiveness of Generic Tofacitinib in the Treatment of Patients with Mild Alopecia Areata in China: A Retrospective Real-World Study
- MICROAGULHAMENTO ASSOCIADO AO MINOXIDIL PARA O TRATAMENTO DA ALOPECIA AREATA DE BARBA NÃO CICATRICIAL: UMA REVISÃO BIBLIOGRAFICA
- Elevation of transaminases after MMP® session with methotrexate for alopecia areata treatment – how much do we know about the risks of systemic absorption of the technique?
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Three-microneedle device as an effective option for intralesional corticosteroid administration for the treatment of alopecia areata
- Mechanism of action of NLRP3 protein macromolecule based on electrochemical sensors in the treatment of alopecia areata in mice: The role of Ritlecitinib in AA mice through NLRP3
- Selective JAK 1 inhibition with upadacitinib as a potential treatment for coexistent severe atopic dermatitis and alopecia areata